Showing results (301-310 of 333) with videos related to
Sort By:
Pageof 34
Hepatology (Baltimore, Md.)|July 1, 1995
Proliferation-associated differences in the spatial and temporal expression of gap junction genes in rat liverM J Neveu, J R Hully, K L Babcock, et al.The American Journal of Gastroenterology|December 17, 1997
Octreotide inhibition of flushing and colonic motor dysfunction in carcinoid syndromeS B Saslow, M D O'Brien, M Camilleri, et al.The Journal of Clinical Investigation|February 1, 1988
Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failureE Gohda, H Tsubouchi, H Nakayama, et al.Molecular Carcinogenesis|November 1, 1994
Differences in the expression of connexin genes in rat hepatomas in vivo and in vitroM J Neveu, C A Sattler, G L Sattler, et al.Gut|July 11, 1998
Medium-term effects of a new 5HT3 antagonist, alosetron, in patients with carcinoid diarrhoeaS B Saslow, J S Scolapio, M Camilleri, et al.Cancer Research|July 1, 1994
Tamoxifen induces hepatic aneuploidy and mitotic spindle disruption after a single in vivo administration to female Sprague-Dawley ratsL M Sargent, Y P Dragan, N Bahnub, et al.Hepatology (Baltimore, Md.)|January 1, 1991
Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assayH Tsubouchi, Y Niitani, S Hirono, et al.Hepatology (Baltimore, Md.)|June 1, 1989
Clinical significance of human hepatocyte growth factor in blood from patients with fulminant hepatic failureH Tsubouchi, S Hirono, E Gohda, et al.Endocrinologia Japonica|August 1, 1983
Glucagon degradation in fraction of big plasma glucagon in rats treated with carbon tetrachlorideH Tsubouchi, E Gohda, H Miyazaki, et al.Biochemical and Biophysical Research Communications|March 15, 1991
Identification of the N-terminal residue of the heavy chain of both native and recombinant human hepatocyte growth factorY Yoshiyama, N Arakaki, D Naka, et al.Pageof 34